阿托品滴眼液控制近视增长研究新进展

Research Progress of Atropine Eye Drops in Controlling the Growth of Myopia

近视患病率居高不下,且呈现低龄化、快速发展的趋势,成为影响儿童青少年身心健康的社会问题。阿托品作为近视防控药物,临床效果已得到肯定,不同浓度的阿托品滴眼液在近视防控中的有效性和安全性不同。本文对近年发表的关于低浓度阿托品滴眼液在控制儿童近视增长方面的文献进行综述,并对阿托品的近视防控研究进行展望,以期对读者有所裨益。

The prevalence of myopia shows a trend of younger age and rapid development,which has become a social problem affecting the physical and mental health of children and adolescents.As a drug for myopia prevention and control,the clinical effect of atropine has been affirmed,and the effectiveness and safety of different concentrations of atropine are different.In our present paper,we reviewed the published literatures about low concentration of atropine eye drops in the control of myopia growth in children,and discussed the research prospect of atropine in myopia prevention and control.